|
Market Cap (22-Jun) $292,012,800 (943rd) |
Close (30-Jun) $0.350 |
Volume (30-Jun) 313,271 |
Shortsold (6-Jun) 238,849 (0.10%) (425th) |
|
52w High $1.79 |
52w Low $0.350 |
P/E - |
EPS -0.02 |
OCC released this announcement to the ASX on 5 February 2021, 9:51. The announcement is marked as price sensitive, and is 2 page(s) in length and 184.61kb in size.
You can view all announcements from OCC and see how they appear on a price chart on the announcements page.
At the date of this announcement, OCC was 0.710% short sold according to ASIC data. It was ranked the 225th most shorted stock on the ASX. It remains ranked 425th as of the latest reported data (06 June 2025).
| Other Recent Announcements from OCC | |
|---|---|
| Orthocell receives A$3.17m R&D tax incentive refund | 21 June 2023, 9:00 |
| Change of Director's Interest Notice - Paul Anderson | 16 June 2023, 9:08 |
| Change of Director's Interest Notice - Paul Anderson | 13 June 2023, 9:25 |
| CelGro Recommended for Reimbursement | 5 February 2021, 9:51 |
| Appendix 4C - Quarterly | 29 January 2021, 17:18 |
| Change of Director's Interest Notice * 5 | 29 January 2021, 17:14 |
| Novel Surgical Treatment for Tendon Repair | 28 January 2021, 9:41 |
You must be logged in to post a reply.
Orthocell 